GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
More evidence suggests that medications such as Ozempic and Mounjaro, originally developed for diabetes and then approved for ...
GLP-1 medications such as Ozempic may help lower the risk of certain cancers. GLP-1 medications such as Ozempic and Wegovy ...
GLP-1 drugs, like Ozempic and Wegovy have been associated with a lower risk of cancer in diabetics according to a new study.
Obesity increases the risk of developing a number of cancers, so it stands to reason that drugs that reduce body weight should also reduce the risk of developing these cancers. Researchers in the ...
Blockbuster weight-loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are ...
People taking diabetes drugs such as GLP-1RAs saw a significant reduction in their risk of 10 out of 13 obesity-associated ...
People with type 2 diabetes who were given a type of weight-loss drug had a much lower risk of developing 10 out of 13 obesity-related cancers compared to those who received insulin, a new study has ...
July 17, 2024 — Pet cats may be excellent animal models for the study of obesity origins and treatment in humans, a new study of feline gut microbes suggests -- and both species would likely get ...
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a ...
Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests. Patients with Type 2 ...
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a study that ...